According to V. Šilinsas, following a meeting with the Prime Minister, a significant portion of global economies, specifically eight out of ten countries, remain ensnared in the middle-income trap. Šilinsas noted that while competing on the basis of lower-cost goods is not inherently difficult, achieving advanced economic status requires a different approach.
He emphasized that true wealth generation depends on mastering the ability to compete in fields where other nations lack capability. He highlighted biotechnology as a prime example of this specialized area of expertise, asserting that this sector represents a domain where Lithuania possesses the capacity to produce high-level products unmatched by other nations. The immediate focus, he stated, must be on developing strategies to increase this contribution to 5% of the national GDP through biotechnology.
Šilinsas confirmed that Prime Minister M. Sinkevičius views the biotechnology sector as a national priority. Consequently, he anticipates a collaborative effort between the state and the private business sector to expand and strengthen this crucial industry.
Furthermore, he pointed out that Lithuania has not fully leveraged the resources available from European Union biotechnology funding. Therefore, he strongly recommended that the nation improve the effectiveness and scope of its utilization of these international funds. The discussion centered on identifying the specific competencies—the “what”—that can propel Lithuania beyond current economic plateaus.
By strategically investing in unique scientific and technological sectors like biotech, the nation aims to transition from merely participating in global trade to leading specialized, high-value production areas.
Topics: #what #area #countries
